Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Qiagen (QGEN) over the last 10 years, with Q4 2024 value amounting to $82.7 million.

  • Qiagen's Other Accumulated Expenses rose 3160.19% to $82.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $82.7 million, marking a year-over-year increase of 3160.19%. This contributed to the annual value of $82.7 million for FY2024, which is 3160.19% up from last year.
  • According to the latest figures from Q4 2024, Qiagen's Other Accumulated Expenses is $82.7 million, which was up 3160.19% from $62.8 million recorded in Q4 2023.
  • Qiagen's Other Accumulated Expenses' 5-year high stood at $82.7 million during Q4 2024, with a 5-year trough of $59.2 million in Q4 2022.
  • Its 5-year average for Other Accumulated Expenses is $67.7 million, with a median of $66.6 million in 2021.
  • In the last 5 years, Qiagen's Other Accumulated Expenses tumbled by 1111.6% in 2022 and then soared by 3160.19% in 2024.
  • Over the past 5 years, Qiagen's Other Accumulated Expenses (Quarter) stood at $67.2 million in 2020, then fell by 0.97% to $66.6 million in 2021, then decreased by 11.12% to $59.2 million in 2022, then grew by 6.14% to $62.8 million in 2023, then soared by 31.6% to $82.7 million in 2024.
  • Its Other Accumulated Expenses stands at $82.7 million for Q4 2024, versus $62.8 million for Q4 2023 and $59.2 million for Q4 2022.